Government vendor
Emergent BioDefense Operations Lansing LLC
Contracts with the federal government, Dec 2008 to Oct 2019.
- Federal contracts
- $11.6M
- 4 contracts
- Buyers
- 1
- departments and agencies
- Non-competitive
- 100%
- of 1 contracts that say how they were awarded
- First and latest
- 2008–2019
Federal contracts over $10,000, contracts dated Jan 2004 to Sep 2026, each counted once at its latest reported value. Source: Treasury Board proactive publication of contracts, published October 13, 2026.
See this vendor’s records on the government’s contract search
Who it sells to
| Department or agency | Contracts | Total |
|---|---|---|
| National Defence | 4 | $11.6M |
What it sells
By the Treasury Board object code each contract was filed under.
| Category | Contracts | Total |
|---|---|---|
| Pharmaceutical and Other Medicinal Products | 1 | $6.1M |
Largest contracts
| Date | Buyer | What | How awarded | Value |
|---|---|---|---|---|
| Oct 2019 | National Defence | Pharmaceutical and Other Medicinal Products | Advance contract award notice | $6,119,214 |
| Dec 2012 | National Defence | Drugs and Biologicals | — | $2,904,900 |
| Dec 2008 | National Defence | Drugs and Biologicals | — | $1,586,340 |
| Sep 2015 | National Defence | Drugs and Biologicals | — | $984,300 |
By year
| Year | Contracts | Total |
|---|---|---|
| 2008 | 1 | $1.6M |
| 2012 | 1 | $2.9M |
| 2015 | 1 | $984K |
| 2019 | 1 | $6.1M |
Federal contracts
Newest first. Each at its latest reported value, amendments included.
| Date | Buyer | What | How awarded | Value |
|---|---|---|---|---|
| Oct 2019 | National Defence | Pharmaceutical and Other Medicinal Products | Advance contract award notice | $6,119,214 |
| Sep 2015 | National Defence | Drugs and Biologicals | — | $984,300 |
| Dec 2012 | National Defence | Drugs and Biologicals | — | $2,904,900 |
| Dec 2008 | National Defence | Drugs and Biologicals | — | $1,586,340 |
CanadaBuys award notices
Contracts this vendor won through CanadaBuys since 2022.
| Awarded | Supplier | What | Buyer | Value |
|---|---|---|---|---|
| Feb 2026 | Emergent BioDefense Operations Lansing | Tembexa (brincidofovir) Smallpox antiviral | Public Health Agency of Canada (PHAC) | $12,148,810 |
CanadaBuys award notices since Aug 2022. They overlap the Treasury Board contract figures and are never added to them. Source: CanadaBuys open data, October 12, 2026.